-
Diagnostics World | One patient’s near-death experience leads to a thought-provoking encounter with family planning and the booming field of genetic counseling.
Oct 12, 2017
-
STAT | Increasingly popular ovarian reserve tests run the risk of giving women an inaccurate impression of their future chances of having children.
Oct 10, 2017
-
Diagnostics World | One of the overarching concerns about direct-to-consumer genetic testing is that the general public’s access to genetic information could result in misunderstandings or harmful health-related decisions. Researchers are looking actively for ways to make sure that doesn't happen.
Oct 5, 2017
-
Forbes | Once Tyler Shultz got to Theranos, he found out that “everyone kind of knew that this thing didn’t actually live up to what we were claiming.” As Shultz starts his own company, Flux Biosciences, his experience with Theranos affects how he talks about his business.
Oct 4, 2017
-
Diagnostics World Podcast | Neeta Vora of University of North Carolina Chapel Hill is featured on this podcast from Cambridge Healthtech Institute in preparation for the 5th annual Advances in Prenatal Molecular Diagnostics conference. Topics include technical challenges and issues surrounding patient counseling, the potential for performing exome sequencing on noninvasively obtained samples, and more.
Oct 4, 2017
-
MIT Technology Review | An audacious Chinese entrepreneur wants to test your body for everything. But are computers really smart enough to make sense of all that data?
Oct 3, 2017
-
Diagnostics World | Major depressive disorder (MDD) affects more than 16 million adults in the United States, yet there is still much that is unknown or not clearly understood about the condition. Researchers are investigating the reasons behind the many questions that still linger about how MDD occurs, and a number of recent studies are opening new paths of inquiry that may one day lead to changes in how depression is diagnosed and treated.
Oct 2, 2017
-
MIT Technology Review | Maryland and New York still restrict who can order genetic tests and how companies can market them.
Sep 28, 2017
-
Diagnostics World | MeMed has released the results from an external, double-blinded clinical study in a recent edition of Pediatrics. The study, known as PATHFINDER, showed how MeMed’s novel blood test, ImmunoXpert, accurately distinguishes between bacterial and viral infections in children.
Sep 27, 2017
-
Diagnostics World | September featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including N-of-One, PerkinElmer, SpeeDx, and more.
Sep 26, 2017
-
The New York Times | Aaron Hernandez, the former New England Patriots tight end and a convicted murderer, was 27 when he committed suicide in April. Yet a posthumous examination of his brain showed he had such a severe form of the degenerative brain disease C.T.E. that the damage was akin to that of players well into their 60s.
Sep 22, 2017
-
STAT | Gene tests are starting to help sort out whether immunotherapy will work for individual cancer patients — or whether it might backfire.
Sep 20, 2017
-
UNMC | Jacob Duncan, a third-year Pharm.D. candidate at the UNMC College of Pharmacy, recently won first place in the national Pharmacy Student Point-of-Care Disease Management Competition at the ninth-annual Next Generation Dx Summit in Washington, D.C.
Sep 19, 2017
-
Diagnostics World Contributed Commentary | After years of alternating centralization and decentralization of diagnostic assays, we are finally entering an era of smart testing in which location is chosen based on what’s best for the patient.
Sep 18, 2017
-
Diagnostics World Video | Diagnostics is a tricky space right now, says Charles Mathews, Vice President of Boston Healthcare. He spends lot of his time focusing on reimbursement and at last month’s Next Generation Dx Summit in Washington, D.C., he outlined some paths around our current payment and reimbursement hurdles.
Sep 14, 2017
-
CNBC |
"This is the moment for digital therapeutics," said Corey McCann, the founder and CEO of Pear Therapeutics.
Sep 14, 2017